HF
BHST

HRT Financial’s BioHarvest Sciences BHST Stock Holding History

HRT Financial’s Portfolio BHST Stock Details BHST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,632
Closed -$75K – 4970
2025
Q4 		$75K Buy
+14,632
New +$117K ﹤0.01% 2827

Other funds holding BHST

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return
TNA
True North Advisors Dallas, Texas $1.05B AUM 22.99% 1-Year Est. Return
EWM
Evercore Wealth Management New York $7.07B AUM 24.72% 1-Year Est. Return
MFG
Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

HRT Financial's BHST Position: Q1 2026 in Review

HRT Financial sold out of BioHarvest Sciences (BHST) in Q1 2026, closing a stake of 14,632 shares — an estimated $75K sold.

HRT Financial first reported a position in BHST in Q4 2025 and held it in 1 quarter. The position peaked at $75K in Q4 2025. 20 funds tracked by Wall St. Rank hold BHST as of Q1 2026.

  • HRT Financial reported no remaining BioHarvest Sciences position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 14,632 BioHarvest Sciences shares in Q1 2026, an estimated $75K.
  • HRT Financial first reported a position in BioHarvest Sciences in Q4 2025 and held it in 1 quarter.
  • HRT Financial's BioHarvest Sciences position peaked at $75K in Q4 2025.
  • 20 funds tracked by Wall St. Rank held BioHarvest Sciences as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.